Qiagen NV | QIA - Current Assets


Qiagen NV reported $2B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
argenx SE USD 6.9B 1.07B Dec/2025
Avita Medical AUD 35.49M 760K Dec/2025
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
Moderna USD 5.77B 774M Mar/2026
Organon & Co USD 4.93B 580M Mar/2026
Qiagen NV USD 2B 535.87M Dec/2025
Revvity USD 2.13B 111.43M Mar/2026
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Viatris USD 10.92B 1.13B Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026